Medtronic stock trades 27% beneath our $112 good value estimate. The biggest pure-Perform clinical-gadget maker is really a vital lover for its hospital buyers, thanks to its diversified item portfolio targeted at a wide range of Long-term disorders, Morningstar senior analyst Debbie Wang clarifies.